GSK PLC SP. ADR/2 NEW Cash Flow Quality Index
GSK PLC SP. ADR/2 NEW cash flow quality index. GSK PLC SP. ADR/2 NEW (GS70) has a Cash Flow Quality Index of 6.18x as of June 2026. Operating cash flow of €2.69 Billion exceeds net income of €435.00 Million, indicating high earnings quality where cash backs reported profits. See GS70 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of GSK PLC SP. ADR/2 NEW (2021–2025)
Cash flow quality index of GSK PLC SP. ADR/2 NEW from 2021 to 2025. Historical Cash Flow Quality Index for GSK PLC SP. ADR/2 NEW across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore GSK PLC SP. ADR/2 NEW (GS70) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
GSK PLC SP. ADR/2 NEW Cash Flow Quality Index by Year (2021–2025)
GSK PLC SP. ADR/2 NEW cash flow quality index by year from 2021 to 2025. Year-by-year earnings quality comparison for GSK PLC SP. ADR/2 NEW. For the full cash flow conversion analysis, see GSK PLC SP. ADR/2 NEW (GS70) cash conversion ratio.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.35x | €7.74 Billion | €5.72 Billion | ▼ -46.8% |
| 2024 | 2.55x | €6.55 Billion | €2.58 Billion | ▲ +85.3% |
| 2023 | 1.37x | €6.77 Billion | €4.93 Billion | ▲ +177.5% |
| 2022 | 0.49x | €7.40 Billion | €14.96 Billion | ▼ -72.7% |
| 2021 | 1.81x | €7.95 Billion | €4.38 Billion | — |